All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-MAP2K2 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-1886-FY | CBFYM-0010 | Human | Human | IgG1 | ||
DMAb-1887-FY | CBFYM-0039 | Mouse | Human | IgG1, k | Synthetic peptide corresponding to amino acid residues near the C-terminus conjugated to KLH | |
DMAb-1888-FY | CBFYM-0075 | Mouse | Human | IgG2b, k | Anti-MEK2 Monoclonal Antibody was produced in mice by repeated immunizations with synthetic peptide corresponding to amino acid residues near the N-terminus conjugated to KLH | |
DMAb-1889-FY | CBFYM-0162 | Mouse | Human | IgG | Recombinant human MEK2 Protein | |
DMAb-1890-FY | CBFYM-0451 | Rabbit | Human | IgG | ||
DMAb-1891-FY | CBFYM-1442 | Mouse | Human | IgG1 | ||
DMAb-1892-FY | CBFYM-1443 | Mouse | Human | IgG1 | Synthetic peptide corresponding to a portion of N-terminal MKK2 (MAP kinase kinase 2) | |
DMAb-1893-FY | CBFYM-1444 | Mouse | Human | IgG2a | ||
DMAb-1894-FY | CBFYM-1445 | Mouse | Human | IgG1 | ||
DMAb-1895-FY | CBFYM-1446 | Mouse | Human | IgG1 | Synthetic peptide conjugated to KLH | |
DMAb-1896-FY | CBFYM-1447 | Mouse | Human | IgG1 | Recombinant fragment of human MAP2K2 expressed in E. coli | |
DMAb-1897-FY | CBFYM-1448 | Mouse | Human | IgG1, k | MEK2 antibody was raised in Mouse using a recombinant human protein purified from E.coli (His-MEK2) | |
DMAb-1898-FY | CBFYM-1449 | Mouse | Human | IgG1 | Full length human recombinant protein of human MAP2K2(NP_109587) produced in HEK293T cell | |
DMAb-1899-FY | CBFYM-1450 | Mouse | Human | IgG1 | Protein expressed in 293T cell transfected with human MAP2K2 expression vector | |
DMAb-1900-FY | CBFYM-1451 | Mouse | Human | IgG2b | Recombinant protein encompassing a sequence within the center region of human MEK2 | |
DMAb-1901-FY | CBFYM-1452 | Rabbit | Human | IgG | Synthetic peptide corresponding to the C-terminal region of human MEKK2 | |
DMAb-1902-FY | CBFYM-1453 | Mouse | Human | IgG2b, k | Recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.Immunogen sequence: MLARRKPVLP ALTINPTIAE GPSPTSEGAS EANLVDLQKK LEELELDEQQ KKRLEAFLTQ KAKVGELKDD DFERISELGA GNGGVVTKVQ HRPSGLIMAR KLIHLEIKPA IRNQIIRELQ VLHECNSPYI VGFYGAFYSD GEISICMEHM DGGSLDQVLK EAKRIPEEIL GKVSIAVLRG LAYLREKHQI MHRDVKPSNI LVNSRGEIKL CDFGVSGQLI DSMANSFVGT RSYMAPERLQ GTHYSVQSDI WSMGLSLVEL AVGRYPIPPP DAKELEAIFG RPVVDGEEGE PHSISPRPRP PGRPVSGHGM DSRPAMAIFE LLDYIVNEPP PKLPNGVFTP DFQEFVNKCL IKNPAERADL | |
DMAb-1903-FY | CBFYM-1454 | Mouse | Human | IgG1 | ||
DMAb-1904-FY | CBFYM-1455 | Rabbit | Human | IgG | ||
DMAb-1905-FY | CBFYM-1456 | Mouse | Human | IgG2a | Recombinant Protein | |
DMAb-1906-FY | CBFYM-1457 | Mouse | Human | IgG2a | Full length human recombinant protein of human MAP2K2 (NP_109587) produced in HEK293T cell | |
DMAb-1907-FY | CBFYM-1458 | Mouse | Human | IgG1 | Recombinant fragment of human MAP2K2 expressed in E. coli | |
DMAb-1908-FY | CBFYM-1459 | Mouse | Human | IgG2a | E. coli-derived recombinant human MEK2, Met1-Val400 | |
DMAb-1909-FY | CBFYM-1460 | Mouse | Human | IgG1 | ||
DMAb-1910-FY | CBFYM-1461 | Mouse | Human | |||
DMAb-1911-FY | CBFYM-1462 | Rabbit | Human | IgG | ||
DMAb-1912-FY | CBFYM-1463 | Rabbit | Human | IgG | Synthetic peptide corresponding to the N-terminal region of human MEK2 | |
DMAb-1913-FY | CBFYM-1464 | Mouse | Human | Recombinant protein | ||
DMAb-1914-FY | CBFYM-1465 | Mouse | Human | IgG1 |
There are currently no customer reviews or questions for Anti-MAP2K2 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1886-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION